{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:09:36Z","timestamp":1793660976676,"version":"4.5.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271804"],"award-info":[{"award-number":["82271804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270018"],"award-info":[{"award-number":["82270018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370020"],"award-info":[{"award-number":["82370020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Suzhou Science and Education - Driven Healthcare Strengthening Project","award":["ZDXM2024008"],"award-info":[{"award-number":["ZDXM2024008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To examine chemokine expression in children with Respiratory Syncytial Virus (RSV) bronchiolitis and evaluate its clinical utility for early warning and prognosis. Five hospitalised RSV bronchiolitis children and five matched controls were studied. To validate findings, 50 RSV infants and 30 controls were assessed for recurrent wheezing after 1\u00a0year. Blood leukocyte RNA-seq identified RSV-associated hub genes via GO\/KEGG analysis, with flow cytometry confirming chemokine expression. Twelve hub genes were identified, with 712 differentially expressed genes (292 upregulated, 420 downregulated). RSV patients showed elevated CXCL2, CXCL12, CXCL13, CCL13, and CCL24 (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). CXCL12 was higher in moderate-to-severe cases (Area Under the Curve, AUC\u2009=\u20090.835, 95% CI 0.714\u20130.956,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05), while CXCL13 was elevated in recurrent wheezers (AUC\u2009=\u20090.851, 95% CI 0.711\u20130.991,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). CXCL12 predicted severity, and CXCL13 predicted recurrence (ROC-confirmed,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). CXCL12 and CXCL13 may serve as biomarkers for assessing RSV bronchiolitis severity and predicting recurrence, aiding early clinical evaluation and prognosis.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-31062-6","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T09:55:18Z","timestamp":1765187718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CXCL12 and CXCL13 as potential biomarkers for disease severity and recurrence in respiratory syncytial virus bronchiolitis"],"prefix":"10.1038","volume":"16","author":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuena","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangli","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heting","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"31062_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102089","volume":"61","author":"B Abu-Raya","year":"2023","unstructured":"Abu-Raya, B., Vineta Paramo, M., Reicherz, F. & Lavoie, P. M. Why has the epidemiology of RSV changed during the COVID-19 pandemic?. EClinicalMedicine. 61, 102089 (2023).","journal-title":"EClinicalMedicine."},{"issue":"10","key":"31062_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.36863","volume":"6","author":"M Bourdeau","year":"2023","unstructured":"Bourdeau, M. et al. Pediatric RSV-associated hospitalizations before and during the COVID-19 pandemic. JAMA Netw. Open. 6(10), e2336863 (2023).","journal-title":"JAMA Netw. Open."},{"issue":"4","key":"31062_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(23)00630-8","volume":"24","author":"B Cong","year":"2024","unstructured":"Cong, B. et al. Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: A systematic analysis. Lancet Infect Dis. 24(4), 361\u2013374 (2024).","journal-title":"Lancet Infect Dis."},{"issue":"26","key":"31062_CR4","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1056\/NEJMoa2309189","volume":"389","author":"SB Drysdale","year":"2023","unstructured":"Drysdale, S. B. et al. Nirsevimab for prevention of hospitalizations due to RSV in infants. N. Engl. J. Med. 389(26), 2425\u20132435 (2023).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"31062_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41541-024-00912-1","volume":"9","author":"C Bissett","year":"2024","unstructured":"Bissett, C. et al. Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine. NPJ Vaccines. 9(1), 118 (2024).","journal-title":"NPJ Vaccines."},{"key":"31062_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880368","volume":"13","author":"S Esposito","year":"2022","unstructured":"Esposito, S. et al. RSV prevention in all infants: Which Is the most preferable strategy?. Front. Immunol. 13, 880368 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"31062_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12879-021-05937-8","volume":"21","author":"S Chen","year":"2021","unstructured":"Chen, S.et al. Risk factors for recurrent wheezing after bronchiolitis in infants: 2-year follow up in China. BMC Infect Dis. 21(1), 250 (2021).","journal-title":"BMC Infect Dis."},{"issue":"4","key":"31062_CR8","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jaci.2023.08.009","volume":"152","author":"C Rosas-Salazar","year":"2023","unstructured":"Rosas-Salazar, C., Hasegawa, K. & Hartert, T. V. Progress in understanding whether respiratory syncytial virus infection in infancy causes asthma in childhood. J. Allergy Clin. Immunol. 152(4), 866\u2013869 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"31062_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1164\/ajrccm\/145.1.106","volume":"145","author":"EE Wang","year":"1992","unstructured":"Wang, E. E., Milner, R. A., Navas, L. & Maj, H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am. Rev. Respir. Dis. 145(1), 106\u2013109 (1992).","journal-title":"Am. Rev. Respir. Dis."},{"issue":"5","key":"31062_CR10","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","volume":"134","author":"SL Ralston","year":"2014","unstructured":"Ralston, S. L. et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 134(5), e1474\u2013e1502 (2014).","journal-title":"Pediatrics"},{"issue":"6","key":"31062_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/ppul.24007","volume":"53","author":"I Golan-Tripto","year":"2018","unstructured":"Golan-Tripto, I. et al. Modified Tal Score: Validated score for prediction of bronchiolitis severity. Pediatr. Pulmonol. 53(6), 796\u2013801 (2018).","journal-title":"Pediatr. Pulmonol."},{"issue":"12","key":"31062_CR12","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/thx.2009.121582","volume":"65","author":"N Sigurs","year":"2010","unstructured":"Sigurs, N. et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65(12), 1045\u20131052 (2010).","journal-title":"Thorax"},{"issue":"Suppl 7","key":"31062_CR13","doi-asserted-by":"publisher","first-page":"S648","DOI":"10.1093\/infdis\/jiaa208","volume":"222","author":"D Oner","year":"2020","unstructured":"Oner, D. et al. Biomarkers for disease severity in children infected with respiratory syncytial virus: A systematic literature review. J. Infect. Dis. 222(Suppl 7), S648\u2013S657 (2020).","journal-title":"J. Infect. Dis."},{"issue":"17","key":"31062_CR14","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.3390\/jcm12175501","volume":"12","author":"SJ Romero-Tapia","year":"2023","unstructured":"Romero-Tapia, S. J., Guzman Priego, C. G., Del-Rio-Navarro, B. E. & Sanchez-Solis, M. Advances in the relationship between respiratory viruses and asthma. J. Clin. Med. 12(17), 5501 (2023).","journal-title":"J. Clin. Med."},{"key":"31062_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2023.100062","volume":"4","author":"R Chaudhary","year":"2023","unstructured":"Chaudhary, R., Meher, A., Krishnamoorthy, P. & Kumar, H. Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection. Curr. Res. Immunol. 4, 100062 (2023).","journal-title":"Curr. Res. Immunol."},{"issue":"14","key":"31062_CR16","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.3390\/ijms22147371","volume":"22","author":"T Khare","year":"2021","unstructured":"Khare, T., Bissonnette, M. & Khare, S. CXCL12-CXCR4\/CXCR7 axis in colorectal cancer: Therapeutic target in preclinical and clinical studies. Int. J. Mol. Sci. 22(14), 7371 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"31062_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2147\/JIR.S259633","volume":"13","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. NLRP3 regulated CXCL12 expression in acute neutrophilic lung injury. J. Inflamm. Res. 13, 377\u2013386 (2020).","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"31062_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12275-023-00018-8","volume":"61","author":"S Chen","year":"2023","unstructured":"Chen, S., Tang, W., Yu, G., Tang, Z. & Liu, E. CXCL12\/CXCR4 axis is involved in the recruitment of NK cells by HMGB1 contributing to persistent airway inflammation and AHR during the late stage of RSV infection. J. Microbiol. 61(4), 461\u2013469 (2023).","journal-title":"J. Microbiol."},{"key":"31062_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fendo.2019.00585","volume":"10","author":"EM Garcia-Cuesta","year":"2019","unstructured":"Garcia-Cuesta, E. M.et al. The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases. Front. Endocrinol. (Lausanne). 10, 585 (2019).","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"31062_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-pharmtox-010919-023340","volume":"61","author":"MJ Smit","year":"2021","unstructured":"Smit, M. J. et al. The CXCL12\/CXCR4\/ACKR3 axis in the tumor microenvironment: Signaling, crosstalk, and therapeutic targeting. Annu. Rev. Pharmacol. Toxicol. 61, 541\u2013563 (2021).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"31062_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2015.11.001","volume":"100","author":"V Vanheule","year":"2016","unstructured":"Vanheule, V. et al. Basic chemokine-derived glycosaminoglycan binding peptides exert antiviral properties against dengue virus serotype 2, herpes simplex virus-1 and respiratory syncytial virus. Biochem. Pharmacol. 100, 73\u201385 (2016).","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"31062_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","volume":"20","author":"S Cambier","year":"2023","unstructured":"Cambier, S., Gouwy, M. & Proost, P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell. Mol. Immunol. 20(3), 217\u2013251 (2023).","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"31062_CR23","first-page":"6700","volume":"8","author":"H Chen","year":"2015","unstructured":"Chen, H. et al. CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1\/2. Int. J. Clin. Exp. Pathol. 8(6), 6700\u20136707 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"5","key":"31062_CR24","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3892\/etm.2016.3141","volume":"11","author":"H Chen","year":"2016","unstructured":"Chen, H. et al. CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response. Exp. Ther. Med. 11(5), 1865\u20131870 (2016).","journal-title":"Exp. Ther. Med."},{"key":"31062_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cyto.2018.01.014","volume":"110","author":"W Alturaiki","year":"2018","unstructured":"Alturaiki, W. et al. Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of respiratory syncytial virus infection. Cytokine 110, 267\u2013271 (2018).","journal-title":"Cytokine"},{"issue":"10","key":"31062_CR26","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1128\/JVI.00259-16","volume":"90","author":"A Sharma","year":"2016","unstructured":"Sharma, A. et al. Respiratory syncytial virus (RSV) pulmonary infection in humanized mice induces human anti-RSV immune responses and pathology. J. Virol. 90(10), 5068\u20135074 (2016).","journal-title":"J. Virol."},{"issue":"10","key":"31062_CR27","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3390\/v15101999","volume":"15","author":"A Agac","year":"2023","unstructured":"Agac, A. et al. Host responses to respiratory syncytial virus infection. Viruses. 15(10), 1999 (2023).","journal-title":"Viruses."},{"key":"31062_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3389\/fendo.2019.00471","volume":"10","author":"MG Kazanietz","year":"2019","unstructured":"Kazanietz, M. G., Durando, M. & Cooke, M. CXCL13 and its receptor CXCR5 in cancer: Inflammation, immune response, and beyond. Front. Endocrinol. (Lausanne). 10, 471 (2019).","journal-title":"Front. Endocrinol. (Lausanne)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31062-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:32:39Z","timestamp":1768235559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31062-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31062"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31062-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from the legal guardians of the subjects. All procedures were conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of Children\u2019s Hospital of Soochow University (No. 2022CS108).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from parents and\/or legal guardians of all minor participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"1514"}}